CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT

A. Pichon-Riviere,J. Caporale,A. Alcaraz,A. Bardach,K. Klein,L. R. Ares and F. Augustovski. CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT. Value in Health. 2013;16(7):10.1016/j.jval.2013.08.2126.